Activation of Hedgehog Pathway in Gastrointestinal Cancers

Ling Yang, Xiulan Su, Jingwu Xie

Research output: Contribution to journalArticle

8 Scopus citations


The hedgehog (Hh) pathway is a major regulator for cell differentiation, tissue polarity, and cell proliferation in embryonic development and homeostasis in adult tissue. Studies from many laboratories reveal activation of this pathway in a variety of human cancer, including basal cell carcinomas (BCCs), medulloblastomas, leukemia, gastrointestinal, lung, ovarian, breast, and prostate cancers. It is thus believed that targeted inhibition of Hh signaling may be effective in treatment and prevention of human cancer. Even more exciting is the discovery and synthesis of specific signaling antagonists for the Hh pathway, which have significant clinical implications in novel cancer therapeutics. In this review, we summarize major advances in the past 2 years in our understanding of Hh signaling activation in human gastrointestinal cancer and their potential in clinical treatment with Hh pathway inhibitors.

Original languageEnglish
Pages (from-to)461-472
Number of pages12
JournalVitamins and Hormones
StatePublished - 2012


  • Gastrointestinal cancer
  • Hedgehog
  • Human cancer
  • Inhibitor
  • Therapy

ASJC Scopus subject areas

  • Endocrinology
  • Physiology

Fingerprint Dive into the research topics of 'Activation of Hedgehog Pathway in Gastrointestinal Cancers'. Together they form a unique fingerprint.

  • Cite this